Dopavision GmbH
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| MyopiaX Treatment for the Reduction of Myopia Progression in Children and Adolescents: Safety and Efficacy Investigation (NCT04967287) | Dopavision GmbH | 2021-11-16 |
Track Dopavision GmbH automatically
Every clearance here is in the API, with alerts when new ones post.